R

RADX

Radiopharm Theranostics Ltd

3.99

-0.08-1.97%
After Hours: 4.360  +0.370  +9.27%19:25 04/28 EDT

Financial Statements

Statement:

Key indicator

Income Statement

Balance Sheet

Cash Flow

Reporting Period:

Accumulated Report

FY

YoY:
FY: Financial Year Annual Report
Q: Quarter is quarterly reports. Q1, Q2, Q3 and Q4 are reports for a single quarter. Q6 and Q9 are accumulated quarterly reports, respectively contain 6 months' reports and 9 months' report.
Item
FY 2024
FY 2023
FY 2022
FY 2021
Cash from Operating Activities

-22.98M

-23.20M

-9.91M

-32.91K

Net Income

--

--

--

--

Depreciation/Depletion & Amortization

--

--

--

--

Deferred Taxes

--

--

--

--

Non-Cash Items

--

--

--

--

Changes in Working Capital

4.90M

1.70M

8.83K

--

Cash from Investing Activities

0

-1.53M

-28.38M

0

Capital Expenditures

0

-1.53M

-28.34M

--

Other Investing Cash Flow Items, Total

--

0

-40.00K

0

Cash from Financing Activities

29.88M

9.22M

65.11M

60.00K

Financing Cash Flow Items

-1.97M

-854.76K

-4.83M

--

Total Cash Dividends Paid

--

--

--

--

Issuance (Retirement) of Stock, Net

29.65M

10.07M

70.00M

1.00K

Issuance (Retirement) of Debt, Net

2.20M

0

-59.00K

59.00K

Foreign Exchange Effects

-25.04K

234.65K

127.37K

--

Net Change in Cash

6.88M

-15.28M

26.95M

27.09K

Cash Interest Paid

--

--

--

--

Cash Taxes Paid

--

--

--

--